BRIEF-EMA says Novartis withdraws marketing application for Ruvise

LONDON Thu Jan 24, 2013 9:22am EST

Related Topics

LONDON, Jan 24 (Reuters) - * Ema press release: novartis europharm ltd withdraws its

marketingauthorisation application for ruvise (imatinib mesilate) (id:humtop)

FILED UNDER: